Phase II clinical trial - Appareil pulmonaire
FRACTION-LUNG (CA018-001)
Appareil pulmonaire
Essai clinique fermé
Public cible
Adulte
A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Subjects with Advanced Non-small Cell Lung Cancer (FRACTION-Lung)
Description de l'essai
The purpose of this study is to determine whether Nivolumab, in combination with other therapies, is more effective than Nivolumab by itself in patients with advanced Non-Small Cell lung cancer.
Liens utiles
EMANUELA ROMANO
Investigateur principal